Research programme: RANTES analogues - Scientific Institute San RaffaeleAlternative Names: RANTES analogues research programme - San Raffaele Scientific Institute
Latest Information Update: 27 Aug 2001
At a glance
- Originator Nonindustrial source; Scientific Institute San Raffaele
- Developer Nonindustrial source
- Mechanism of Action CCR5 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections